Table of Contents
International Journal of Peptides
Volume 2017, Article ID 9454583, 10 pages
https://doi.org/10.1155/2017/9454583
Research Article

Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin

1Department of Pediatrics, Eastern Virginia Medical School, 700 West Olney Road, Norfolk, VA 23507, USA
2Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, 700 West Olney Road, Norfolk, VA 23507, USA
3Children’s Specialty Group, 811 Redgate Avenue, Norfolk, VA 23507, USA
4Children’s Hospital of The King’s Daughters, 601 Children’s Lane, Norfolk, VA 23507, USA

Correspondence should be addressed to Neel K. Krishna; ude.smve@knnhsirk

Received 12 April 2017; Revised 6 July 2017; Accepted 3 August 2017; Published 10 September 2017

Academic Editor: Tzi Bun Ng

Copyright © 2017 Pamela S. Hair et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Berg, J. L. Tymoczko, and L. Stryer, Eds., Biochemistry, WH Freeman and Company, New York, NY, USA, 2007, WH Freeman and Company.
  2. A. I. Alayash, “Oxygen therapeutics: can we tame haemoglobin?” Nature Reviews Drug Discovery, vol. 3, no. 2, pp. 152–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Maitra, J. Byun, P. R. Andreana et al., “Mechanism of hypochlorous acid-mediated heme destruction and free iron release,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 364–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Maitra, J. Byun, P. R. Andreana et al., “Reaction of hemoglobin with HOCl: mechanism of heme destruction and free iron release,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 374–386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kumar and U. Bandyopadhyay, “Free heme toxicity and its detoxification systems in human,” Toxicology Letters, vol. 157, no. 3, pp. 175–188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Schaer and P. W. Buehler, “Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies,” Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Sharp, P. S. Hair, H. K. Pallera et al., “Peptide inhibitor of complement C1 (PIC1) rapidly inhibits complement activation after intravascular injection in rats,” PLoS ONE, vol. 10, no. 7, Article ID e0132446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Sharp, P. H. Whitley, K. M. Cunnion, and N. K. Krishna, “Peptide inhibitor of complement C1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential,” Frontiers in Immunology, vol. 5, article 406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. S. Hair, L. A. Sass, N. K. Krishna, and K. M. Cunnion, “Inhibition of myeloperoxidase activity in cystic fibrosis sputum by peptide inhibitor of complement C1 (PIC1),” PLoS ONE, vol. 12, no. 1, Article ID e0170203, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Shah, C. T. Mauriello, P. S. Hair et al., “Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis,” Transfusion, vol. 54, no. 11, pp. 2892–2900, 2014. View at Publisher · View at Google Scholar
  11. A. Hasmann, E. Wehrschuetz-Sigl, A. Marold et al., “Analysis of myeloperoxidase activity in wound fluids as a marker of infection,” Annals of Clinical Biochemistry, vol. 50, no. 3, pp. 245–254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kothari, R. S. Keshari, J. Bogra et al., “Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis,” Journal of Critical Care, vol. 26, no. 4, pp. 435.e1–435.e7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. T. Mauriello, H. K. Pallera, J. A. Sharp et al., “A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility,” Molecular Immunology, vol. 53, no. 1-2, pp. 132–139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Maitra, F. Shaeib, I. Abdulhamid et al., “Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway,” Free Radical Biology and Medicine, vol. 63, pp. 90–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Huang, F. Smith, and P. Panizzi, “Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs,” Archives of Biochemistry and Biophysics, vol. 548, pp. 74–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Huang, F. Smith, J. R. Panizzi, D. C. Goodwin, and P. Panizzi, “Inactivation of myeloperoxidase by benzoic acid hydrazide,” Archives of Biochemistry and Biophysics, vol. 570, pp. 14–22, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Juarez-Moreno, M. Ayala, and R. Vazquez-Duhalt, “Antioxidant capacity of poly(ethylene glycol) (PEG) as protection mechanism against hydrogen peroxide inactivation of peroxidases,” Applied Biochemistry and Biotechnology, vol. 177, no. 6, pp. 1364–1373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Atmaca, “Antioxidant effects of sulfur-containing amino acids,” Yonsei Medical Journal, vol. 45, no. 5, pp. 776–788, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. L. O. Chavez, M. Leon, S. Einav, and J. Varon, “Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice,” Critical Care, vol. 20, no. 1, article 135, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. A. J. Kettle, C. A. Gedye, and C. C. Winterbourn, “Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide,” Biochemical Journal, vol. 321, no. 2, pp. 503–508, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. L. B. Poole, “The basics of thiols and cysteines in redox biology and chemistry,” Free Radical Biology & Medicine, vol. 80, pp. 148–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Q. Gronemus, P. S. Hair, K. B. Crawford, J. O. Nyalwidhe, K. M. Cunnion, and N. K. Krishna, “Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein,” Molecular Immunology, vol. 48, no. 1-3, pp. 305–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. S. Kumar, H. K. Pallera, P. S. Hair et al., “Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats,” Transfusion, vol. 56, no. 8, pp. 2133–2145, 2016. View at Publisher · View at Google Scholar · View at Scopus